Manulife Financial-S (00945) announces third quarter results, core profit of 2.1 billion Canadian dollars, up 4% year-on-year

According to the Zhitong Finance App, Manulife Finance-S (00945) announced the results for the third quarter of 2026. Core profit recorded $2.1 billion, up 4% from the third quarter of 2025 on a fixed exchange rate basis; net income attributable to shareholders was $1.4 billion, down $400 million from the third quarter of 2025; core EPS was 1.24 Canadian dollars, up 6% from the third quarter of 2025; EPS was 0.82 Canadian dollars, down 21% from the third quarter of 2025; core ROE was 17.8%, ROE was 11.8%; “Life Insurance Capital Adequacy Test” (LICAT) ratio was 136%; APE sales, CSM2 and The value of the new manufacturing business 5 is roughly similar to the third quarter of 2025; the global wealth and asset management business recorded a net outflow of 3.6 billion Canadian dollars, while the third quarter of 2025 recorded a net outflow of 6.2 billion Canadian dollars.

“Our third quarter results were strong, with core EPS reaching a record high and core ROE of 17.8%, mainly due to double-digit growth in core earnings in Asia and significant contributions from the North American insurance business. “These results reflect our rigorous implementation of the strategy we launched a year ago, and demonstrate our ability to achieve continued growth in an uncertain market environment.”

“This quarter, we optimized investment and protection products to provide customers with more choices; completed the largest fundraising ever on Manulife | Comvest's Comvest private equity credit platform; expanded the application of AI enabling solutions to bring tangible results to customers and financial advisors; and promoted new health and longevity programs and partnerships. These initiatives are strengthening our competitive advantage, deepening customer relationships, and creating long-term value for shareholders.”

— Phil Witherington (Phil Witherington), President and CEO of Manulife

“This quarter, we continued to prudently allocate capital and return $1.3 billion to shareholders while maintaining a steady balance and liability situation. The LICAT ratio was 136%, and the financial leverage ratio was lower than our mid-term target. Furthermore, we have completed an annual review of our actuarial methods and assumptions, which has had an overall net positive impact, further confirming the soundness of our reserves.”

“While continuing to invest in the growth of our various businesses, we also further improved our cost efficiency this quarter. Our financial flexibility and consistent execution provide a good foundation for continuing to create long-term value.”

— Colin Simpson, Manulife's CFO